6-methylsulfinylhexyl-isothiocyanate and Leukemia

6-methylsulfinylhexyl-isothiocyanate has been researched along with Leukemia* in 2 studies

Other Studies

2 other study(ies) available for 6-methylsulfinylhexyl-isothiocyanate and Leukemia

ArticleYear
6-(Methylsulfonyl) Hexyl Isothiocyanate: A Chemopreventive Agent Inducing Autophagy in Leukemia Cell Lines.
    Biomolecules, 2022, Oct-14, Volume: 12, Issue:10

    Autophagy is a fundamental catabolic process of cellular survival. The role of autophagy in cancer is highly complex: in the early stages of neoplastic transformation, it can act as a tumor suppressor avoiding the accumulation of proteins, damaged organelles, and reactive oxygen species (ROS), while during the advanced stages of cancer, autophagy is exploited by cancer cells to survive under starvation. 6-(Methylsulfonyl) hexyl isothiocyanate (6-MITC) is the most interesting compound in the

    Topics: Apoptosis; Autophagy; Cell Line, Tumor; Cytostatic Agents; HL-60 Cells; Humans; Isothiocyanates; Leukemia; Reactive Oxygen Species

2022
Wasabi Compound 6-(Methylsulfinyl) Hexyl Isothiocyanate Induces Cell Death with Coexisting Mitotic Arrest and Autophagy in Human Chronic Myelogenous Leukemia K562 Cells.
    Biomolecules, 2019, 11-23, Volume: 9, Issue:12

    Topics: Autophagy; Cell Cycle Checkpoints; Cell Death; Histones; Humans; Isothiocyanates; K562 Cells; Leukemia; Mitosis; Plant Extracts; Wasabia

2019